print
Oklahoma Judge Shaves $107 Million Off Opioid Decision Against Johnson & Johnson
by applewood

    Balkman's original ruling on Aug. 26 caused confusion among attorneys on both sides over his calculations and whether the $572 million represented the final amount or just one installment in a larger payment plan.

    So on Friday, he revised that number. The roughly $107 million shaved off the August judgment appears to correct a math error that Balkman has acknowledged making. At a hearing last month, he said he had set aside $107.6 million to support programs treating addiction in babies exposed to opioids in the womb — when really he meant to set aside roughly $107,600.